Cresset Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Cresset Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,659	Closed	-$423K	–	1948
2023 Q3	$423K	Sell	3,659 -1,057	-22%	-$114K	﹤0.01%	1264
2023 Q2	$485K	Buy	4,716 +1,371	+41%	+$145K	﹤0.01%	1299
2023 Q1	$365K	Buy	+3,345	New	+$370K	0.01%	572
2022 Q4	–	Sell	-5,130	Closed	-$317K	–	931
2022 Q3	$317K	Sell	5,130 -197	-4%	-$13.8K	﹤0.01%	654
2022 Q2	$422K	Buy	5,327 +1,713	+47%	+$162K	0.01%	613
2022 Q1	$381K	Buy	3,614 +711	+24%	+$69.3K	﹤0.01%	692
2021 Q4	$313K	Sell	2,903 -693	-19%	-$75.6K	﹤0.01%	867
2021 Q3	$393K	Buy	3,596 +1,175	+49%	+$122K	0.01%	718
2021 Q2	$227K	Buy	+2,421	New	+$223K	﹤0.01%	901
2019 Q2	–	Sell	-20	Closed	-$1K	–	2070
2019 Q1	$1K	Buy	+20	New	+$474	﹤0.01%	1952

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cresset Asset Management's HZNP Position: Q4 2023 in Review

Cresset Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 3,659 shares — an estimated $423K sold.

Cresset Asset Management first reported a position in HZNP in Q1 2019 and held it in 10 quarters. The position peaked at $485K in Q2 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Cresset Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Cresset Asset Management sold 3,659 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $423K.
Cresset Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and held it in 10 quarters.
Cresset Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $485K in Q2 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Cresset Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.